Document Detail

Arctigenin Anti-Tumor Activity in Bladder Cancer T24 Cell Line Through Induction of Cell-Cycle Arrest and Apoptosis.
MedLine Citation:
PMID:  22619087     Owner:  NLM     Status:  Publisher    
Bladder cancer is the most common neoplasm in the urinary system. This study assesses arctigenin anti-tumor activity in human bladder cancer T24 cells in vitro and the underlying molecular events. The flow cytometry analysis was used to detect cell-cycle distribution and apoptosis. Western blotting was used to detect changes in protein expression. The data showed that arctigenin treatment reduced viability of bladder cancer T24 cells in a dose- and time-dependent manner after treatment with arctigenin (10, 20, 40, 80, and 100 μmol/L) for 24 hr and 48 hr. Arctigenin treatment clearly arrested tumor cells in the G1 phase of the cell cycle. Apoptosis was detected by hoechst stain and flow cytometry after Annexin-V-FITC/PI double staining. Early and late apoptotic cells were accounted for 2.32-7.01% and 3.07-7.35%, respectively. At the molecular level, arctigenin treatment decreased cyclin D1 expression, whereas CDK4 and CDK6 expression levels were unaffected. Moreover, arctigenin selectively altered the phosphorylation of members of the MAPK superfamily, decreasing phosphorylation of ERK1/2 and activated phosphorylation of p38 significantly in a dose-dependent manner. These results suggest that arctigenin may inhibit cell viability and induce apoptosis by direct activation of the mitochondrial pathway, and the mitogen-activated protein kinase pathway may play an important role in the anti-tumor effect of arctigenin. The data from the current study demonstrate the usefulness of arctigenin in bladder cancer T24 cells, which should further be evaluated in vivo before translation into clinical trials for the chemoprevention of bladder cancer. Anat Rec, 2012. © 2012 Wiley Periodicals, Inc.
Shucai Yang; Jing Ma; Jianbing Xiao; Xiaohong Lv; Xinlei Li; Huike Yang; Ying Liu; Sijia Feng; Yafang Zhang
Related Documents :
11070117 - Extrapulmonary lymphangioleiomyomatosis (lam): clinicopathologic features in 22 cases.
16118057 - Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, ...
20162617 - Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of d...
455387 - The characterization of human uterine smooth muscle cells in culture.
17196237 - Acute effects of an anatoxin-a producing cyanobacterium on juvenile fish-cyprinus carpi...
24738847 - Regulation of cardiomyocyte proliferation during development and regeneration.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-23
Journal Detail:
Title:  Anatomical record (Hoboken, N.J. : 2007)     Volume:  -     ISSN:  1932-8494     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101292775     Medline TA:  Anat Rec (Hoboken)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Department of Anatomy, Harbin Medical University, Harbin, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficie...
Next Document:  Aggregation and inactivation of pancreatic cystatin by riboflavin-derived singlet oxygen and flavin ...